Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead's CEO John Martin: Worth The Money?
Seeking Alpha
Mon, 04/6/15 - 06:08 pm
Gilead Sciences
John Martin
executive pay
Gilead Q1 Hep C Sales Look Ahead Of Consensus
Barron's
Mon, 04/6/15 - 05:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
M&A
Merck
Jazz Pharmaceuticals
Shire
Biomarin
Gilead Sciences
Seattle Genetics
Pfizer
Celgene
Actavis seeking FDA Approval to market generic version of Gilead drug
Marketwatch
Fri, 04/3/15 - 10:35 am
Actavis
FDA
generics
Gilead Sciences
Letairis
PAH
Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?
Motley Fool
Wed, 04/1/15 - 08:45 am
Gilead Sciences
Achillion
hepatitis C
Sovaldi
Harvoni
Gilead's huge Sovaldi payoff yields a nice 23% pay hike for CEO
Fierce Pharma
Mon, 03/30/15 - 09:19 pm
Gilead Sciences
Sovaldi
executive pay
John Martin
Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
Motley Fool
Mon, 03/30/15 - 11:13 am
drug launches
Bluebird Bio
LentiGlobin BB305
aducanumab
Biogen Idec
Gilead Sciences
Harvoni
Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
Motley Fool
Sun, 03/29/15 - 11:53 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie
Viekira Pak
Gilead Sciences: Harvoni Going Strong, Sovaldi Not So Much
Barron's
Fri, 03/27/15 - 12:01 pm
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
Gilead Sciences: Big in Japan?
Barron's
Thu, 03/26/15 - 12:57 pm
Gilead Sciences
Japan
hepatitis C
Sovaldi
The $600 million man: Gilead CEO's stock gains push compensation way past estimates
Fierce Pharma
Thu, 03/26/15 - 07:39 am
Gilead Sciences
executive pay
John Martin
Gilead Warning of Hep C Patient Death on Heart Med Will Have “Zero Impact”
WSJ Pharmalot
Mon, 03/23/15 - 11:40 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead Warns After Hepatitis Patient on Heart Drug Dies
Yahoo/Bloomberg
Sun, 03/22/15 - 10:45 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Drug Spending Is Soaring: 3 Takeaways You Can't Miss
Motley Fool
Sun, 03/22/15 - 10:43 am
drug spending
Gilead Sciences
AbbVie
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/20/15 - 01:13 pm
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
Gilead Sciences' Drugs: Worth $136 Billion?
Investopedia
Fri, 03/20/15 - 08:09 am
Gilead Sciences
Harvoni
Sovaldi
Charity attacks Gilead over hepatitis C drug restrictions
Yahoo/Reuters
Wed, 03/18/15 - 08:06 pm
Gilead Sciences
Sovaldi
Harvoni
hepatitis C
developing countries
This Policy Shift Is Big News for Gilead Sciences
Investopedia
Wed, 03/18/15 - 08:05 am
Gilead Sciences
Harvoni
Sovaldi
Gilead Sciences: How Big a Threat is Merck?
Barron's
Tue, 03/17/15 - 07:17 pm
Merck
Gilead Sciences
hepatitis C
Gilead's hepatitis C drugs largely cost-effective in U.S. -study
Yahoo/Reuters
Tue, 03/17/15 - 10:13 am
Gilead Sciences
hepatitis C
Sovaldi
Pages
« first
‹ previous
…
62
63
64
65
66
67
68
69
70
…
next ›
last »